A Landscape Analysis of Oligonucleotide-Based Therapies

Time: 11:00 am
day: Day One


  • Breaking down the oligonucleotide drug and trial landscape – a look into diseases, delivery systems & nucleic acid modifications across modalities
  • Comparing the drug & trial landscape within the CNS & beyond
  • A look into the future of the field & upcoming activity